Contineum Therapeutics Inc (CTNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||
| Net Income | -42,258 | 22,720 | -24,253 |
| Depreciation Amortization | 258 | -3 | 483 |
| Accounts payable and accrued liabilities | 1,141 | N/A | -230 |
| Other Working Capital | 5,334 | -1,024 | -1,267 |
| Other Operating Activity | 2,680 | -2,344 | 5,146 |
| Operating Cash Flow | $-32,845 | $19,349 | $-20,121 |
| Cash Flows From Investing Activities | |||
| Change In Deposits | -69,245 | -65,154 | 22,417 |
| PPE Investments | -494 | -414 | -118 |
| Investing Cash Flow | $-69,739 | $-65,568 | $22,299 |
| Cash Flows From Financing Activities | |||
| Debt Repayment | N/A | -3,750 | -1,250 |
| Common Stock Issued | 109,001 | 159 | 15 |
| Common Stock Repurchased | N/A | -28 | -4 |
| Other Financing Activity | 0 | 59,795 | 0 |
| Financing Cash Flow | $109,001 | $56,176 | $-1,239 |
| Beginning Cash Position | 15,526 | 5,569 | 4,630 |
| End Cash Position | 21,943 | 15,526 | 5,569 |
| Net Cash Flow | $6,417 | $9,957 | $939 |
| Free Cash Flow | |||
| Operating Cash Flow | -32,845 | 19,349 | -20,121 |
| Capital Expenditure | -514 | -414 | -118 |
| Free Cash Flow | -33,359 | 18,935 | -20,239 |